SACUVAL 50 MG BOX OF 30

SACUVAL is indicated to reduce the risk of cardiovascular mortality and morbidity in adult patients with systolic heart failure (NYHA class II–VI, LVEF < 40%).
SACUVAL is administered in combination, as appropriate, with other treatments for heart failure (e.g., beta-blockers, diuretics, and mineralocorticoid receptor antagonists) instead of an ACE inhibitor or an ARB.

Description

Speciality SACUVAL
Strength 50 mg
Pharmaceutical Form Film-coated tablet
Packaging Box of 30
INN Sacubitril + Valsartan
Laboratory PHILADELPHIA PHARMA
Therapeutic Class Cardiovascular System
Sub-class Agents acting on the renin–angiotensin system
Packaging Type Blister
Specification ALU formpack / ALU
Schedule A
Shelf Life 24 months

Reviews

There are no reviews yet.

Be the first to review “SACUVAL 50 MG BOX OF 30”